Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.2.2
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 08, 2022
Mar. 28, 2022
Mar. 15, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2020
Feb. 23, 2021
Class of Stock [Line Items]                    
Fair value of warrants         $ (214,000)    
Warrant and rights issued       431,537     431,537      
Warrants and rights outstanding       458,598     458,598      
Cancer Genetics Inc Merger [Member]                    
Class of Stock [Line Items]                    
Warrants and rights outstanding       429,820     429,820      
Preferred Stock Warrants [Member]                    
Class of Stock [Line Items]                    
Conversion of warrants into stock             8,621      
Series A Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock, shares outstanding                 4,611,587  
Shares exchanged for common stock                 1,194,701  
Series B Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock, shares outstanding                 3,489,470  
Shares exchanged for common stock                 904,834  
Series C Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Payments of Stock Issuance Costs               $ 214,000    
Shares exchanged for common stock             139,879      
Stock Issued During Period, Value, Conversion of Convertible Securities     $ 2,000,000.0              
Lincoln Park Capital Fund LLC [Member]                    
Class of Stock [Line Items]                    
Payments of Stock Issuance Costs       $ 0     $ 250,000      
Purchase Agreement [Member] | Lincoln Park Capital Fund LLC [Member]                    
Class of Stock [Line Items]                    
Issuance of Incremental shares to StemoniX shareholders upon Merger, shares   81,190                
Agreement description   Under the Purchase Agreement, the Company may from time to time for 30 months following May 9, 2022 (the “Commencement Date”), at its discretion, direct Lincoln Park to purchase on any single business day, or a Regular Purchase, up to (i) 10,000 common shares, (ii) 15,000 common shares if the closing sale price of its common shares is not below $7.50 per share on Nasdaq or (iii) 20,000 common shares if the closing sale price of its common shares is not below $12.50 per share on Nasdaq                
Purchase Agreement [Member] | Lincoln Park Capital Fund LLC [Member] | Maximum [Member]                    
Class of Stock [Line Items]                    
Aggregate offering price   $ 15,000,000.0                
Sales Agreement [Member] | Canaccord Genuity LLC [Member]                    
Class of Stock [Line Items]                    
Commission percentage 3.00%                  
Fees and disbursements $ 75,000                  
Sales Agreement [Member] | Canaccord Genuity LLC [Member] | Maximum [Member]                    
Class of Stock [Line Items]                    
Aggregate offering price $ 20,000,000                  
Merger Agreement [Member]                    
Class of Stock [Line Items]                    
Warrant to purchase shares                   28,778
Warrants exercise price                   $ 29.5295
Fair value of warrants           $ 214,000        
Merger Agreement [Member] | Investor Warrant [Member]                    
Class of Stock [Line Items]                    
Fair value of warrants             $ 421,000